Long-term data of the new transcutaneous partially implantable bone conduction hearing system Osia®

PURPOSE: The new active transcutaneous partially implantable osseointegrated system Cochlear™ Osia® System is indicated in case of conductive or mixed hearing loss (CHL/MHL) with a maximum average bone conduction hearing loss of 55 dB, or in single-sided deafness (SSD). The implant directly stimulat...

Descripción completa

Detalles Bibliográficos
Autores principales: Rauch, Ann-Kathrin, Wesarg, Thomas, Aschendorff, Antje, Speck, Iva, Arndt, Susan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2021
Materias:
Otology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9363475/
https://www.ncbi.nlm.nih.gov/pubmed/34792628
http://dx.doi.org/10.1007/s00405-021-07167-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9363475/
https://www.ncbi.nlm.nih.gov/pubmed/34792628
http://dx.doi.org/10.1007/s00405-021-07167-9

Ejemplares similares